Crossref journal-article
Springer Science and Business Media LLC
Nature Medicine (297)
Bibliography

Roy, K., Mao, H.-Q., Huang, S.-K., & Leong, K. W. (1999). Oral gene delivery with chitosan–DNA nanoparticles generates immunologic protection in a murine model of peanut allergy. Nature Medicine, 5(4), 387–391.

Authors 4
  1. Krishnendu Roy (first)
  2. Hai-Quan Mao (additional)
  3. Shau -Ku Huang (additional)
  4. Kam W. Leong (additional)
References 35 Referenced 926
  1. Yocum, M.W. & Khan, D.A. Assessment of patients who have experienced anaphylaxis: a 3-year survey [see comments]. Mayo Clin. Proc. 69, 16–23 (1994). (10.1016/S0025-6196(12)61606-1) / Mayo Clin. Proc. by MW Yocum (1994)
  2. Kemp, S.F., Lockey, R.F., Wolf, B.L. & Lieberman, P. Anaphylaxis. A review of 266 cases [see comments]. Arch. Intern. Med. 155, 1749–1754 (1995). (10.1001/archinte.1995.00430160077008) / Arch. Intern. Med. by SF Kemp (1995)
  3. Sampson, H.A., Mendelson, L. & Rosen, J.P. Fatal and near-fatal anaphylactic reactions to food in children and adolescents [see comments]. N. Engl. J. Med. 327, 380–384 (1992). (10.1056/NEJM199208063270603) / N. Engl. J. Med. by HA Sampson (1992)
  4. Yunginger, J.W. et al. Fatal food-induced anaphylaxis. J. Am. Med. Assoc. 260, 1450–1452 ( 1988). (10.1001/jama.1988.03410100140041) / J. Am. Med. Assoc. by JW Yunginger (1988)
  5. Snider, D.P., Marshall, J.S., Perdue, M.H. & Liang, H. Production of IgE antibody and allergic sensitization of intestinal and peripheral tissues after oral immunization with protein Ag and cholera toxin. J. Immunol. 153, 647–657 (1994). (10.4049/jimmunol.153.2.647) / J. Immunol. by DP Snider (1994)
  6. Lycke, N., Severinson, E. & Strober, W. Cholera toxin acts synergistically with IL-4 to promote IgG1 switch differentiation. J. Immunol. 145, 3316–3324 (1990). (10.4049/jimmunol.145.10.3316) / J. Immunol. by N Lycke (1990)
  7. Munoz, E., Zubiaga, A.M., Merrow, M., Sauter, N.P. & Huber, B.T. Cholera toxin discriminates between T helper 1 and 2 cells in T cell receptor-mediated activation: role of cAMP in T cell proliferation. J. Exp. Med. 172, 95–103 (1990). (10.1084/jem.172.1.95) / J. Exp. Med. by E Munoz (1990)
  8. Nelson, H.S., Lahr, J., Rule, R., Bock, A. & Leung, D. Treatment of anaphylactic sensitivity to peanuts by immunotherapy with injections of aqueous peanut extract. J. Allergy Clin. Immunol. 99, 744–751 (1997). (10.1016/S0091-6749(97)80006-1) / J. Allergy Clin. Immunol. by HS Nelson (1997)
  9. Hsu, C.H. et al. Immunoprophylaxis of allergen-induced immunoglobulin E synthesis and airway hyperresponsiveness in vivo by genetic immunization [see comments]. Nature Med. 2, 540– 544 (1996). (10.1038/nm0596-540) / Nature Med. by CH Hsu (1996)
  10. Hsu, C.H., Chua, K.Y., Tao, M.H., Huang, S.K. & Hsieh, K.H. Inhibition of specific IgE response in vivo by allergen-gene transfer. Int. Immunol. 8, 1405– 1411 (1996). (10.1093/intimm/8.9.1405) / Int. Immunol. by CH Hsu (1996)
  11. Raz, E. et al. Preferential induction of a Th1 immune response and inhibition of specific IgE antibody formation by plasmid DNA immunization. Proc. Natl. Acad. Sci. USA 93, 5141– 5145 (1996). (10.1073/pnas.93.10.5141) / Proc. Natl. Acad. Sci. USA by E Raz (1996)
  12. Pardoll, D.M. & Beckerleg, A.M. Exposing the immunology of naked DNA vaccines. Immunity 3, 165– 169 (1995). (10.1016/1074-7613(95)90085-3) / Immunity by DM Pardoll (1995)
  13. Ulmer, J.B. et al. Induction of immunity by DNA vaccination: application to influenza and tuberculosis. Behring Inst. Mitt. 98, 79–86 (1997). / Behring Inst. Mitt. by JB Ulmer (1997)
  14. Wang, B. et al. Gene inoculation generates immune responses against human immunodeficiency virus type 1. Proc. Natl. Acad. Sci. USA 90, 4156–4160 (1993). (10.1073/pnas.90.9.4156) / Proc. Natl. Acad. Sci. USA by B Wang (1993)
  15. Raz, E. et al. Intradermal gene immunization: the possible role of DNA uptake in the induction of cellular immunity to viruses. Proc. Natl. Acad. Sci. USA 91, 9519–9523 ( 1994). (10.1073/pnas.91.20.9519) / Proc. Natl. Acad. Sci. USA by E Raz (1994)
  16. Etchart, N., Buckland, R., Liu, M.A., Wild, T.F. & Kaiserlian, D. Class I-restricted CTL induction by mucosal immunization with naked DNA encoding measles virus haemagglutinin. J. Gen. Virol. 78, 1577–1580 ( 1997). (10.1099/0022-1317-78-7-1577) / J. Gen. Virol. by N Etchart (1997)
  17. Leong, K.W. et al. DNA-polycation nanospheres as non-viral gene delivery vehicles J. Controlled Release 53, 183– 193 (1998). (10.1016/S0168-3659(97)00252-6) / J. Controlled Release by KW Leong (1998)
  18. Lee, W.Y. et al. Toxicities of 166Holmium-chitosan in mice. Arzneimittelforschung 48, 300–304 ( 1998). / Arzneimittelforschung by WY Lee (1998)
  19. Aspden, T.J. et al. Chitosan as a nasal delivery system: the effect of chitosan solutions on in vitro and in vivo mucociliary transport rates in human turbinates and volunteers. J. Pharm. Sci. 86, 509– 513 (1997). (10.1021/js960182o) / J. Pharm. Sci. by TJ Aspden (1997)
  20. Bodmeier, R., Chen, H.G. & Paeratakul, O. A novel approach to the oral delivery of micro- or nanoparticles. Pharm. Res. 6, 413–417 (1989). (10.1023/A:1015987516796) / Pharm. Res. by R Bodmeier (1989)
  21. Illum, L., Farraj, N.F. & Davis, S.S. Chitosan as a novel nasal delivery system for peptide drugs. Pharm. Res. 11, 1186– 1189 (1994). (10.1023/A:1018901302450) / Pharm. Res. by L Illum (1994)
  22. Miyazaki, S., Nakayama, A., Oda, M., Takada, M. & Attwood, D. Chitosan and sodium alginate based bioadhesive tablets for intraoral drug delivery. Biol. Pharm. Bull. 17, 745–747 (1994). (10.1248/bpb.17.745) / Biol. Pharm. Bull. by S Miyazaki (1994)
  23. Tozaki, H. et al. Chitosan capsules for colon-specific drug delivery: improvement of insulin absorption from the rat colon. J. Pharm. Sci. 86, 1016–1021 (1997). (10.1021/js970018g) / J. Pharm. Sci. by H Tozaki (1997)
  24. Artursson, P., Lindmark, T., Davis, S.S. & Illum, L. Effect of chitosan on the permeability of monolayers of intestinal epithelial cells (Caco-2). Pharm. Res. 11, 1358– 1361 (1994). (10.1023/A:1018967116988) / Pharm. Res. by P Artursson (1994)
  25. Roy, K., Mao, H.Q. & Leong, K.W. DNA-chitosan nanospheres: Transfection efficiency and cellular uptake in The 24th International Symposium on Controlled Release of Bioactive Materials 24, 673– 674 (Stockholm, Sweden, 1997). / The 24th International Symposium on Controlled Release of Bioactive Materials by K Roy (1997)
  26. Wang, Q.F. et al. Peanut-induced anaphylactic response in sensitized mice. J. Allergy Clin. Immunol. 99, 480 (1997). / J. Allergy Clin. Immunol. by QF Wang (1997)
  27. Strober, W. & James, S.P. in Immunology (ed. Stites, D.P.) 541–551 (Appelton Lange, Norwalk, Connecticut, 1994). / Immunology by W Strober (1994)
  28. Chen, S.C. et al. Protective immunity induced by oral immunization with a rotavirus DNA vaccine encapsulated in microparticles. J. Virol. 72, 5757–5761 (1998). (10.1128/JVI.72.7.5757-5761.1998) / J. Virol. by SC Chen (1998)
  29. During, M.J. et al. Peroral gene therapy of lactose intolerance using an adeno-associated virus vector. Nature Med 4, 1131– 1135 (1998). (10.1038/2625) / Nature Med by MJ During (1998)
  30. Kanauchi, O. et al. Increasing effect of a chitosan and ascorbic-acid mixture on fecal dictary-fat excretion. Biosci. Biotechnol. Biochem. 58, 1617–1620 (1994). (10.1271/bbb.58.1617) / Biosci. Biotechnol. Biochem. by O Kanauchi (1994)
  31. Maezaki, Y. et al. Hypercholesterolemic effect of chitosan in adult males. Biosci. Biotechnol. Biochem. 57, 1439– 1444 (1993). (10.1271/bbb.57.1439) / Biosci. Biotechnol. Biochem. by Y Maezaki (1993)
  32. Arai, K., Kinumari, T. & Fujita, T. On the toxicity of chitosan. Bull. Tokal. reg. Fish. Lab. 56, 889 (1968 ). / Bull. Tokal. reg. Fish. Lab. by K Arai (1968)
  33. Takeuchi, H., Yamamoto, H., Niwa, T., Hino, T. & Kawashima, Y. Mucoadhesion of polymer-coated liposomes to rat intestine in vitro. Chem. Pharm. Bull. (Tokyo) 42, 1954–1956 (1994). (10.1248/cpb.42.1954) / Chem. Pharm. Bull. (Tokyo) by H Takeuchi (1994)
  34. Bernkop-Schnurch, A. & Krajicek, M.E. Mucoadhesive polymers as platforms for peroral peptide delivery and absorption: synthesis and evaluation of different chitosan-EDTA conjugates. J. Controlled Release 50, 215–223 ( 1998). (10.1016/S0168-3659(97)00136-3) / J. Controlled Release by A Bernkop-Schnurch (1998)
  35. Ferrari, F., Rossi, S., Bonferoni, M.C., Caramella, C. & Karlsen, J. Characterization of rheological and mucoadhesive properties of three grades of chitosan hydrochloride. Farmaco 52, 493–497 ( 1997). / Farmaco by F Ferrari (1997)
Dates
Type When
Created 23 years ago (July 26, 2002, 4:43 a.m.)
Deposited 2 years, 3 months ago (May 18, 2023, 6:22 p.m.)
Indexed 19 hours, 47 minutes ago (Aug. 23, 2025, 12:58 a.m.)
Issued 26 years, 4 months ago (April 1, 1999)
Published 26 years, 4 months ago (April 1, 1999)
Published Print 26 years, 4 months ago (April 1, 1999)
Funders 0

None

@article{Roy_1999, title={Oral gene delivery with chitosan–DNA nanoparticles generates immunologic protection in a murine model of peanut allergy}, volume={5}, ISSN={1546-170X}, url={http://dx.doi.org/10.1038/7385}, DOI={10.1038/7385}, number={4}, journal={Nature Medicine}, publisher={Springer Science and Business Media LLC}, author={Roy, Krishnendu and Mao, Hai-Quan and Huang, Shau -Ku and Leong, Kam W.}, year={1999}, month=apr, pages={387–391} }